435 related articles for article (PubMed ID: 3699565)
1. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
Ruppin DC; Murphy GM; Dowling RH
Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
[TBL] [Abstract][Full Text] [Related]
2. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.
Lanzini A; Northfield TC
Gut; 1990 Feb; 31(2):226-30. PubMed ID: 2311984
[TBL] [Abstract][Full Text] [Related]
3. Ursocholic acid: bile acid and bile lipid dose response and clinical studies in patients with gall stones.
Howard PJ; Gleeson D; Murphy GM; Dowling RH
Gut; 1989 Jan; 30(1):97-103. PubMed ID: 2920932
[TBL] [Abstract][Full Text] [Related]
4. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones.
Iser JH; Maton PN; Murphy GM; Dowling RH
Br Med J; 1978 Jun; 1(6126):1509-12. PubMed ID: 656777
[TBL] [Abstract][Full Text] [Related]
5. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
Sahlin S; Ahlberg J; Angelin B; Reihnér E; Einarsson K
Gut; 1991 Dec; 32(12):1554-7. PubMed ID: 1773966
[TBL] [Abstract][Full Text] [Related]
6. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
Northfield TC; Hofmann AF
Gut; 1975 Jan; 16(1):1-11. PubMed ID: 806491
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary sucrose on factors influencing cholesterol gall stone formation.
Werner D; Emmett PM; Heaton KW
Gut; 1984 Mar; 25(3):269-74. PubMed ID: 6698443
[TBL] [Abstract][Full Text] [Related]
8. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
Nakano K; Chijiiwa K
Gut; 1993 May; 34(5):702-7. PubMed ID: 8504975
[TBL] [Abstract][Full Text] [Related]
9. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I
Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
[TBL] [Abstract][Full Text] [Related]
11. The effects of phenobarbital on biliary lipid metabolism in cholesterol gallstone subjects.
Redinger RN
Lipids; 1979 Mar; 14(3):277-84. PubMed ID: 449630
[TBL] [Abstract][Full Text] [Related]
12. Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid.
Hussaini SH; Pereira SP; Murphy GM; Kennedy C; Wass JA; Besser GM; Dowling RH
Gut; 1995 Jan; 36(1):126-32. PubMed ID: 7890216
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy.
Walters JR; Hood KA; Gleeson D; Ellul JP; Keightley A; Murphy GM; Dowling RH
Gut; 1992 Mar; 33(3):375-80. PubMed ID: 1568659
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting gall-stone dissolution rate during chenic acid therapy.
Maudgal DP; Kupfer RM; Northfield TC
Gut; 1983 Jan; 24(1):7-10. PubMed ID: 6848433
[TBL] [Abstract][Full Text] [Related]
15. Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids.
Kern F; Everson GT; DeMark B; McKinley C; Showalter R; Braverman DZ; Szczepanik-Van Leeuwen P; Klein PD
J Lab Clin Med; 1982 Jun; 99(6):798-805. PubMed ID: 7077124
[TBL] [Abstract][Full Text] [Related]
16. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.
Shaffer EA; Small DM
J Clin Invest; 1977 May; 59(5):828-40. PubMed ID: 856870
[TBL] [Abstract][Full Text] [Related]
17. Effects of obesity and caloric intake on biliary lipid metabolism in man.
Bennion LJ; Grundy SM
J Clin Invest; 1975 Oct; 56(4):996-1011. PubMed ID: 1159099
[TBL] [Abstract][Full Text] [Related]
18. Diet and gall stones: effects of refined and unrefined carbohydrate diets on bile cholesterol saturation and bile acid metabolism.
Thornton JR; Emmett PM; Heaton KW
Gut; 1983 Jan; 24(1):2-6. PubMed ID: 6293939
[TBL] [Abstract][Full Text] [Related]
19. Diurnal variation in cholesterol saturation of gall-bladder bile.
Kupfer RM; Northfield TC
Gut; 1983 Oct; 24(10):950-3. PubMed ID: 6684613
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol gallstones and biliary lipid metabolism in the primate.
Redinger RN; Grace DM
Gastroenterology; 1978 Feb; 74(2 Pt 1):201-4. PubMed ID: 413761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
